Louis C. Bock, Director at Orexigen Therapeutics, Inc. (OREX), bought 300,000 shares at $7.50 ($2.3M) on 2009-07-27, disclosed to the SEC on 2009-07-28.
Scheduled purchase ($2.2M) by Director.
Nothing distinguishes this filing.
| Filing → |
| OREX | BUY | 2014-11-13 | $151K | — | Filing → |
| ZGNX | BUY | 2011-09-22 | $2.5M | — | Filing → |
| HZNP | BUY | 2011-08-04 | $2.8M | — | Filing → |